Hyliion Holdings Corp.

HYLN Details

Hyliion Holdings Corp. (NYSE: HYLN) is a designer, developer, and marketer of electrified powertrain solutions to reduce carbon intensity and greenhouse gas (GHG) emissions of Class 8 commercial trucks. The company uses its advanced software algorithms and data analytics capabilities, enabling fleets to decrease their fuel and operating expenses and integrate seamlessly with their existing fleet operations. With its electric hybrid system in testing and the Hypertruck ERX system in the prototype phase, the company is at the pre-commercialization stage of development.

Latest News:

Q3FY21 Results:

Key Risks:

Outlook:

HYLN Daily Technical Chart (Source: REFINITIV)

Stock Recommendation:

HYLN's share price has declined 58.67% in the past nine months and is currently leaning towards the lower-band of its 52-week range of USD 5.63 to USD 22.25. The stock is currently trading below its 50 and 200 DMA levels, and its RSI Index is at 33.80.

Considering the significant correction in the stock price, debt-free status, anticipated revenue generation in FY21, current valuation, and associated risks, we recommend a "Speculative Buy" rating on the stock at the current price of USD 6.085, down 2.48% as of December 13, 2021, 12:52 PM ET.

* The reference data in this report has been partly sourced from REFINITIV.

* All forecasted figures and industry information have been taken from REFINITIV.

* Depending upon the risk tolerance, investors may consider unwinding their positions in a respective stock once the estimated target price is reached.

Columbia Care Inc.

CCHWF Details

Columbia Care Inc. (OTC: CCHWF) is a medical cannabis producer, manufacturer, and supplier with licenses in over 18 US and European Union states (EU). The CCHWF has 130 locations, including 99 dispensaries and 31 cultivation and production centers. Some of the most well-known brands include Seed & Strain, Triple Seven, gLeaf, Plant Sugar, and Platinum Label CBD. In addition, the company's new retail brand, Cannabist, emerged in FY21, developing a national dispensary network based on unique technology solutions.

Latest News:

9MFY21 Results:

Key Risks:

Outlook:

FY21 Guidance (Source: Investor Presentation, November 2021)

Valuation Methodology: Price/Sales Per Share Multiple Based Relative Valuation

(Analysis by Kalkine Group)

* % Premium/(Discount) is based on our assessment of the company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.

CCHWF Daily Technical Chart (Source: REFINITIV)

Stock Recommendation:

CCHWF's stock price has fallen 55.04% in the past nine months and is currently leaning towards the lower band of the 52-week range of USD 2.79 to USD 7.89. The stock is currently trading below its 50 and 200 DMA levels, and its RSI Index is at 43.50. We have valued the stock using the Price/Sales-based relative valuation method and arrived at a target price of USD 3.60.

Considering the company's growth prospects, improvement in financials, current valuation, and associated risks, we recommend a "Speculative Buy" rating on the stock at the current price of USD 2.90, down 7.05% as of December 13, 2021, 1:27 PM ET.

*All forecasted figures and Industry Information have been taken from REFINITIV.